Shamburg News · 8-K filed Oct 9, 2026, 4:58 PM EDT
Impact BioMedical Effects 1-for-12.62 Reverse Stock Split Effective September 23, 2026
IBO · IMPACT BIOMEDICAL INC.
- Other event
- Shareholder vote
- Materiality: medium
Impact BioMedical Inc. filed a Certificate of Amendment with the Nevada Secretary of State to effect a one-for-12.62 reverse stock split of its common stock, effective September 23, 2026, at 12:01 A.M. EST. Common stock began trading on a split-adjusted basis on the NYSE American under the ticker IBO and new CUSIP 45259L304. The split reduced outstanding common shares from approximately 107.8 million to approximately 8.6 million, with no fractional shares issued. The filing was delayed because of a clerical processing error at the Nevada Secretary of State's office, with the file-stamped amendment received October 6, 2026.
Source: SEC EDGAR, Form 8-K, Items 5.03, 9.01, accession 0001493152-26-046572.
Written from the filing by Shamburg Markets. Figures are as reported by the company.